Details for New Drug Application (NDA): 040177
✉ Email this page to a colleague
NDA 040177 describes TRIHEXYPHENIDYL HYDROCHLORIDE, which is a drug marketed by Mikart, Pharm Assoc, Pharm Ventures, Hikma, Natco Pharma Ltd, Novitium Pharma, Nylos, Vangard, and Watson Labs, and is included in thirteen NDAs. It is available from nine suppliers. Additional details are available on the TRIHEXYPHENIDYL HYDROCHLORIDE profile page.
The generic ingredient in TRIHEXYPHENIDYL HYDROCHLORIDE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
The generic ingredient in TRIHEXYPHENIDYL HYDROCHLORIDE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
Summary for 040177
| Tradename: | TRIHEXYPHENIDYL HYDROCHLORIDE |
| Applicant: | Pharm Assoc |
| Ingredient: | trihexyphenidyl hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040177
Suppliers and Packaging for NDA: 040177
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TRIHEXYPHENIDYL HYDROCHLORIDE | trihexyphenidyl hydrochloride | ELIXIR;ORAL | 040177 | ANDA | PAI Holdings, LLC dba PAI Pharma | 0121-0658 | 0121-0658-16 | 473 mL in 1 BOTTLE (0121-0658-16) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | ELIXIR;ORAL | Strength | 2MG/5ML | ||||
| Approval Date: | Apr 17, 1997 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
